[Therapeutic value in digestive pathology of a new synthetic substance: 1,1-diphenyl-3-hexamethylene-iminopropane HCl or hexadiphane, associated with dglucitol (sorbitol)].
GAUSSEN
I
I
D001713:Biphenyl Compounds; D002769:Cholelithiasis / Q000628:therapy*; D005762:Gastroenterology / Q000628:therapy*; D008107:Liver Diseases / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000628:therapy*; D010276:Parasympatholytics / Q000628:therapy*; D013012:Sorbitol / Q000628:therapy*
D001713:Biphenyl Compounds; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D013012:Sorbitol; C010574:biphenyl
CHOLELITHIASIS/therapy; GASTROENTEROLOGY/therapy; LIVER DISEASES/therapy; MUSCLE RELAXANTS/therapy; PARASYMPATHOLYTICS/therapy; SORBITOL/therapy